These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17435195)

  • 1. Guillain-Barré syndrome with antibodies to GD1a/GD1b complex.
    Hamaguchi T; Sakajiri K; Sakai K; Okino S; Sada M; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2007 May; 78(5):548-9. PubMed ID: 17435195
    [No Abstract]   [Full Text] [Related]  

  • 2. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome associated with IgG monospecific to ganglioside GD1b.
    Miyazaki T; Kusunoki S; Kaida K; Shiina M; Kanazawa I
    Neurology; 2001 May; 56(9):1227-9. PubMed ID: 11342695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of Guillain-Barré syndrome associated with cerebellar ataxia and positive serum anti-GD1b IgG antibody.
    Sugimoto H; Wakata N; Kishi M; Fujioka T; Kurihara T; Irie Y; Saito T
    J Neurol; 2002 Mar; 249(3):346-7. PubMed ID: 11993539
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection.
    Simpson BS; Rajabally YA
    Eur J Neurol; 2009 Apr; 16(4):e81. PubMed ID: 19222546
    [No Abstract]   [Full Text] [Related]  

  • 8. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S; Kaida K; Ueda M
    Biochim Biophys Acta; 2008 Mar; 1780(3):441-4. PubMed ID: 17976386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S; Kaida K
    J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barré syndrome.
    Pandey JP; Koga M; Yuki N
    Neurogenetics; 2005 Dec; 6(4):225-8. PubMed ID: 16258760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual presentation of Guillain-Barré syndrome associated with monospecific anti-GD1b antibodies.
    Dewil M; Robberecht W; Van Damme P
    J Neurol Neurosurg Psychiatry; 2010 May; 81(5):587-8. PubMed ID: 20460601
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal pharyngeal-cervical-brachial variant of Guillain-Barré syndrome without Anti-GT1a IgG antibody.
    Arai M; Susuki K; Koga M
    Muscle Nerve; 2003 Aug; 28(2):246-50. PubMed ID: 12872333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of ganglioside complex antibodies in Guillain-Barré syndrome.
    Kuijf ML; Godschalk PC; Gilbert M; Endtz HP; Tio-Gillen AP; Ang CW; van Doorn PA; Jacobs BC
    J Neuroimmunol; 2007 Aug; 188(1-2):69-73. PubMed ID: 17604126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.